APPLIED DNA SCIENCES INC (APDN)

Recent Material Events for APPLIED DNA SCIENCES INC
Date Description
Jan 09, 2013 On January 7, 2012, Applied DNA Sciences, Inc. (the “Company”) completed the second closing (“Second Closing”) of its transaction with Crede CG II, Ltd. (“Crede”) and sold 5,500 shares of Series A Convertible Prefe
Dec 20, 2012 Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” a
Dec 05, 2012 (b) On November 30, 2012, Mr. Gerald Catenacci advised the Board of Directors of Applied DNA Sciences, Inc. (the “Company ”) that he would not stand for re-election as a director of the Company at the Company’s 2013 Annual Meeting o
Dec 05, 2012 (b) On November 30, 2012, Mr. Gerald Catenacci advised the Board of Directors of Applied DNA Sciences, Inc. (the “Company ”) that he would not stand for re-election as a director of the Company at the Company’s 2013 Annual Meeting o
Nov 29, 2012 On November 28, 2012, Applied DNA Sciences, Inc. (the “Company”) entered into a securities purchase agreement (“Purchase Agreement”) with Crede CG II, Ltd. (“Crede”). Pursuant to the Purchase Agreement, at the init
Sep 13, 2012 On September 7, 2012, pursuant to Board of Director approval, Applied DNA Sciences, Inc. (the “ Company ”) entered into an indemnification agreement (each, an “ Indemnification Agreement ”) with each of its directors and execu
Jun 26, 2012 Closing on Private Placement . On June 21, 2012, Applied DNA Sciences, Inc. (the “ Company ”) closed a private placement (“ Private Placement ”) of its common stock, par value $0.001 per share (“ Common Stock ”). T
Jan 30, 2012 (a) On January 27, 2012, Applied DNA Sciences, Inc. (the “Company”) amended its Certificate of Incorporation to increase the number of authorized shares of common stock, $0.001 par value per share, from 800,000,000 to 1,350,000,000 shares
Jan 30, 2012 (a) On January 27, 2012, Applied DNA Sciences, Inc. (the “Company”) amended its Certificate of Incorporation to increase the number of authorized shares of common stock, $0.001 par value per share, from 800,000,000 to 1,350,000,000 shares
Dec 09, 2011 Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” a